<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04775472</url>
  </required_header>
  <id_info>
    <org_study_id>CNUH-2020-390</org_study_id>
    <nct_id>NCT04775472</nct_id>
  </id_info>
  <brief_title>Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation</brief_title>
  <acronym>EARLY-UNLOAD</acronym>
  <official_title>Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonnam National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of venoarterial-extracorporeal membrane oxygenation(VA-ECMO) was associated with&#xD;
      lower in-hospital mortality in patients with cardiogenic shock. However, VA-ECMO has a&#xD;
      deleterious effect for hemodynamics. It can increase left ventricular end-diastolic&#xD;
      pressure(LVEDP), followed by left ventricular dilatation, abnormal opening of aortic valve&#xD;
      and jeopardizes of myocardial recovery. Therefore, several methods have been used to reduce&#xD;
      LVEDP. Among these, left atrial septostomy is effective, but less invasive than surgical left&#xD;
      ventricular unloading. However, there is few data regarding this issue. Therefore, the&#xD;
      investigators will evaluate the effect of routine, early left atrial septostomy in patients&#xD;
      with VA-ECMO for the treatment of cardiogenic shock.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Objectives:&#xD;
&#xD;
      To determine the effect of early left atrial septostomy versus conventional approach(left&#xD;
      atrial septostomy only in cases of significant changes due to left ventricular end-diastolic&#xD;
      pressure increase) in patients who received venoarterial-extracorporeal membrane&#xD;
      oxygenation(VA-ECMO) for the treatment of cardiogenic shock.&#xD;
&#xD;
      Study Background:&#xD;
&#xD;
      Cardiogenic shock is due to myocardial dysfunction from multifactorial causes, which has high&#xD;
      mortality. The treatment for cardiogenic shock includes early coronary revascularization,&#xD;
      inotropes, vasopressors, or mechanical circulatory support, such as intraaortic balloon&#xD;
      pump(IABP), VA-ECMO. However, the routine use of IABP is not recommended for the treatment of&#xD;
      cardiogenic shock in recent guidelines. VA-ECMO can be easily implanted, and can maintain&#xD;
      high cardiac output. In several studies, The use of VA-ECMO was associated with lower&#xD;
      in-hospital mortality in patients with cardiogenic shock.&#xD;
&#xD;
      However, VA-ECMO has a deleterious effect for hemodynamics. It can increase left ventricular&#xD;
      end-diastolic pressure(LVEDP), followed by left ventricular dilatation, abnormal opening of&#xD;
      aortic valve and jeopardizes of myocardial recovery. Therefore, several methods have been&#xD;
      used to reduce LVEDP. Among these, left atrial septostomy is effective, but less invasive&#xD;
      than surgical left ventricular unloading. However, there is few data regarding this issue.&#xD;
      Therefore, the investigators will evaluate the effect of routine, early left atrial&#xD;
      septostomy in patients with VA-ECMO for the treatment of cardiogenic shock.&#xD;
&#xD;
      Study Hypothesis:&#xD;
&#xD;
      Early, routine left atrial septostomy for left heart unloading is superior compared to&#xD;
      conventional approach to reduce in-hospital mortality and the duration of VA-ECMO.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 4, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative incidence rate of all-cause death</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>Cumulative incidence rate of all-cause death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence rate of all-cause death during index admission</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Incidence rate of all-cause death during index admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence rate of cardiac death</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>Cumulative incidence rate of cardiac death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence rate of non-cardiac death</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>Cumulative incidence rate of non-cardiac death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weaning rate from venoarterial extracorporeal membrane oxygenation during index admission</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>Weaning rate from venoarterial extracorporeal membrane oxygenation during index admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of disappearance of pulmonary edema on chest X-ray during index admission</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>Rate of disappearance of pulmonary edema on chest X-ray during index admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weaning rate from mechanical ventilator during index admission</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>Weaning rate from mechanical ventilator during index admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of bridge to ventricular assist device or heart transplantation during index admission</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Rate of bridge to ventricular assist device or heart transplantation during index admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of major vascular injury during left atrial septostomy</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>Rate of major vascular injury during left atrial septostomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of cardiac tamponade during left atrial septostomy</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>Rate of cardiac tamponade during left atrial septostomy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Cardiogenic Shock</condition>
  <arm_group>
    <arm_group_label>Early left atrial septostomy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early left atrial septostomy group will routinely receive left atrial septostomy within 12 hours after VA-ECMO implantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional approach group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional approach group will receive left atrial septostomy in cases of deleterious effect of increased LVEDP after VA-ECMO implantation, such as refractory pulmonary edema, abnormal opening of aortic valve, left ventricular dilatation, refractory ventricular tachycardia or fibrillation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early left atrial septostomy within 12 hours after VA-ECMO implantation</intervention_name>
    <description>Early left atrial septostomy group will routinely receive left atrial septostomy within 12 hours after VA-ECMO implantation. Left atrial septostomy will be done using percutaneous technique.</description>
    <arm_group_label>Early left atrial septostomy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Selective left atrial septostomy</intervention_name>
    <description>Left atrial septostomy will be done in cases of deleterious effect of increased LVEDP after VA-ECMO implantation, such as refractory pulmonary edema, abnormal opening of aortic valve, left ventricular dilatation, refractory ventricular tachycardia or fibrillation.</description>
    <arm_group_label>Conventional approach group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1) Age more than 18 years old 2) Cardiogenic shock* 3) Successful VA-ECMO implantation&#xD;
&#xD;
          -  The definition of cardiogenic shock All these criteria should be met&#xD;
&#xD;
               1. Systolic blood pressure &lt; 90 mmHg for 30 minutes, or needing inotrope or&#xD;
                  vasopressor to maintain systolic blood pressure &gt; or = 90 mmHg&#xD;
&#xD;
               2. Pulmonary congestion on chest X-ray or increased left ventricular filling&#xD;
                  pressure by cardiac catheterization&#xD;
&#xD;
               3. At least one criteria of organ dysfunction&#xD;
&#xD;
                  - mental obtundation, clammy skin, oliguria, renal dysfunction, increased level&#xD;
                  of blood lactate&#xD;
&#xD;
                  Exclusion Criteria:&#xD;
&#xD;
               1. VA-ECMO after open heart surgery&#xD;
&#xD;
               2. VA-ECMO for the treatment of non-cardiac shock&#xD;
&#xD;
               3. Severe bleeding*&#xD;
&#xD;
               4. Terminal malignancy&#xD;
&#xD;
               5. Irreversible brain damage&#xD;
&#xD;
               6. Pregnancy or lactation&#xD;
&#xD;
          -  The definition of severe bleeding Hemoglobin decrease after VA-ECMO or cannulation&#xD;
             site bleeding is not a exclusion criteria&#xD;
&#xD;
               1. Hypovolemic shock due to definite bleeding cause&#xD;
&#xD;
               2. Identifiable bleeding causes: gastrointestinal bleeding, hemothorax, traumatic&#xD;
                  bleeding, central nervous system hemorrhage, pulmonary hemorrhage&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min Chul Kim, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonnam National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Min Chul Kim, Professor</last_name>
    <phone>82-62-220-6578</phone>
    <email>kmc3242@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Gwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Chul Kim, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 24, 2021</study_first_submitted>
  <study_first_submitted_qc>February 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonnam National University Hospital</investigator_affiliation>
    <investigator_full_name>Min Chul Kim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Extracorporeal membrane oxygenation</keyword>
  <keyword>Myocardial Infarction</keyword>
  <keyword>Heart Diseases</keyword>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Coronary Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Cardiogenic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

